Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey D Rothstein

Showing results (1-10 of 215) with videos related to

Pageof 22
Sort By:
Nature Medicine|September 3, 2002
Paving new pathwaysJeffrey D Rothstein
Cell|November 4, 2017
Edaravone: A new drug approved for ALSJeffrey D Rothstein
Annals of Neurology|May 1, 2007
TDP-43 in amyotrophic lateral sclerosis: pathophysiology or patho-babel?Jeffrey D Rothstein
Annals of Neurology|April 1, 2003
Of mice and men: reconciling preclinical ALS mouse studies and human clinical trialsJeffrey D Rothstein
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|October 30, 2004
Preclinical studies: how much can we rely on?Jeffrey D Rothstein
Journal of Visualized Experiments : Jove|November 11, 2008
ALS--motor neuron disease: mechanism and development of new therapiesJeffrey D Rothstein
Annals of Neurology|February 5, 2009
Current hypotheses for the underlying biology of amyotrophic lateral sclerosisJeffrey D Rothstein
Neurochemical Research|February 2, 2020
Astrocyte Diversity: Current Insights and Future DirectionsThomas Westergard, Jeffrey D Rothstein
The Journal of Clinical Investigation|September 2, 2017
Oligodendroglia: metabolic supporters of neuronsThomas Philips, Jeffrey D Rothstein
Current Protocols in Pharmacology|September 8, 2015
Rodent Models of Amyotrophic Lateral SclerosisThomas Philips, Jeffrey D Rothstein
Pageof 22

Showing results (1-10 of 215) with videos related to

Sort By:
Pageof 22
Nature Medicine|September 3, 2002
Paving new pathwaysJeffrey D Rothstein
Cell|November 4, 2017
Edaravone: A new drug approved for ALSJeffrey D Rothstein
Annals of Neurology|May 1, 2007
TDP-43 in amyotrophic lateral sclerosis: pathophysiology or patho-babel?Jeffrey D Rothstein
Annals of Neurology|April 1, 2003
Of mice and men: reconciling preclinical ALS mouse studies and human clinical trialsJeffrey D Rothstein
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|October 30, 2004
Preclinical studies: how much can we rely on?Jeffrey D Rothstein
Journal of Visualized Experiments : Jove|November 11, 2008
ALS--motor neuron disease: mechanism and development of new therapiesJeffrey D Rothstein
Annals of Neurology|February 5, 2009
Current hypotheses for the underlying biology of amyotrophic lateral sclerosisJeffrey D Rothstein
Neurochemical Research|February 2, 2020
Astrocyte Diversity: Current Insights and Future DirectionsThomas Westergard, Jeffrey D Rothstein
The Journal of Clinical Investigation|September 2, 2017
Oligodendroglia: metabolic supporters of neuronsThomas Philips, Jeffrey D Rothstein
Current Protocols in Pharmacology|September 8, 2015
Rodent Models of Amyotrophic Lateral SclerosisThomas Philips, Jeffrey D Rothstein
Pageof 22